# Recombinant Versus Highly Purified FSH in Polycystic Ovary Syndrome (PCOS)

> **NCT01337531** · PHASE2 · UNKNOWN · sponsor: **Genesis Center for Fertility & Human Pre-Implantation Genetics** · enrollment: 200 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Gonal-F, Fostimon
- **DRUG:** Gonal-F, Fostimon

## Key facts

- **NCT ID:** NCT01337531
- **Lead sponsor:** Genesis Center for Fertility & Human Pre-Implantation Genetics
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2011-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01337531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01337531, "Recombinant Versus Highly Purified FSH in Polycystic Ovary Syndrome (PCOS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01337531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*